SPC299
Ósílódróstat eða lyfjafræðilega viðunandi salt þar af, að meðtöldu ósílódróstattvívetnisfosfati
Status:
VeittApplication date:
10.6.2020Application published:
15.7.2020Grant published:
15.3.2021
Max expiry date:
12.1.2035Medicine name:
IsturisaMedicine for children:
No
Timeline
Today
10.6.2020Application
15.7.2020Publication
15.3.2021Registration
12.1.2035Expires
Marketing license
IS authorization number:
EU/1/19/1407/001-003Date:
16.1.2020
Foreign authorization number:
EU/1/19/1407Date:
9.1.2020
Owner
Name:
Recordati AGAddress:
Lindenstrasse 8, Baar CH
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113 Reykjavík
Patent
Number:
EP2523731